Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, ...

BNR is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of BNR shares has decreased $0.91 since the market last closed. This is a 3.04% ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

Burning Rock Biotech (BNR) is scheduled to report earnings on December 2, 2025. The last reported earnings were for reported on September 8, 2025 for Q2. The Actual Revenue was $20.7M, which beat the ...